Trial Profile
A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 26 Jul 2016
Price :
$35
*
At a glance
- Drugs Sargramostim (Primary)
- Indications HIV infections; Leucopenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sandoz
- 26 Jul 2016 New trial record